As the first European country to legalize cannabis, Luxembourg has called on other European countries to relax their drug laws, specifically cannabis production and consumption. According to the European state, the continent’s drug policy has not worked over the last few decades, and forbidding everything made it more attractive for people to find new ways of skirting laws.

The country’s relaxed laws will see residents over 18 years old able to buy cannabis for recreational use starting from 2020. The state will establish a cannabis agency to regulate all production and distribution. What’s more, minors between ages 12 and 17 will not face criminal charges if caught in possession of five grams or less of the drug. However, those who break the law will receive harsh penalties.

Read entire article here.

Canadian Licensed Producer Canopy Growth Corporation (TSX: WEED), (NYSE: CGC), is pleased to provide updates on key developments in the United Kingdom and Luxembourg. In these countries, the Company’s pharmaceutical business, Spectrum Therapeutics, continues to expand its sophisticated, pan-European cannabis production and distribution network serving the needs of physicians and their patients. Canopy Growth is committed to transforming healthcare in Europe by providing better access to medical cannabis treatments that have the potential to improve the lives of millions of patients.

Ever since Canada became the first major country to legalize marijuana for adults a year ago, other nations have been paying attention.

The small South American nation of Uruguay was the first to legalize marijuana for adults. New Zealand, Luxembourg and Mexico are among those that have looked to Canada for guidance or lessons, while Russia has chastised it for its “barefaced” flouting of international anti-drug treaties.

Here’s a look at how Canada’s experiment is playing out internationally and where the next attempts at legalization are coming: